www.bmj.com
Open in
urlscan Pro
172.64.155.141
Public Scan
Submitted URL: http://www.bmj.com//
Effective URL: https://www.bmj.com/
Submission: On June 27 via api from US — Scanned from DE
Effective URL: https://www.bmj.com/
Submission: On June 27 via api from US — Scanned from DE
Form analysis 1 forms found in the DOM
Name: PDI_form64555 —
<form style="margin-bottom: 0px; margin-top: 0px;" name="PDI_form64555" id="PDI_form64555">
<div class="css-box pds-box">
<div class="css-box-outer pds-box-outer">
<div class="css-box-inner pds-box-inner">
<div class="css-box-top pds-box-top">
<div class="css-question pds-question">
<div class="css-question-outer pds-question-outer">
<div class="css-question-inner pds-question-inner">
<div class="css-question-top pds-question-top">
<div>Should medical degrees be shortened to four years?</div>
</div>
</div>
</div>
</div>
<div class="css-answer pds-answer"><span id="pds-answer64555" role="group" aria-label="Should medical degrees be shortened to four years?">
<div class="css-answer-group pds-answer-group">
<div class="css-answer-row pds-answer-row"><span class="css-answer-input pds-answer-input"><input class="css-radiobutton pds-radiobutton" type="radio" id="PDI_answer62238793" value="62238793" name="PDI_answer64555"></span><label
for="PDI_answer62238793" class="css-input-label pds-input-label"><span class="css-answer-span pds-answer-span">Yes</span></label><span class="css-clear pds-clear"></span></div>
</div>
<div class="css-answer-group pds-answer-group">
<div class="css-answer-row pds-answer-row"><span class="css-answer-input pds-answer-input"><input class="css-radiobutton pds-radiobutton" type="radio" id="PDI_answer62238794" value="62238794" name="PDI_answer64555"></span><label
for="PDI_answer62238794" class="css-input-label pds-input-label"><span class="css-answer-span pds-answer-span">No</span></label><span class="css-clear pds-clear"></span></div>
</div>
</span></div>
<div class="css-vote pds-vote">
<div class="css-votebutton-outer pds-votebutton-outer"><button id="pd-vote-button64555" type="submit" class="css-vote-button pds-vote-button" value="Vote">Vote</button><span
class="css-links pds-links"><a href="javascript:PD_vote64555(1);" class="css-view-results pds-view-results">View Results</a><br><span class="css-clear pds-clear"></span></span><span class="css-clear pds-clear"></span></div>
</div>
</div>
</div>
</div>
</div>
</form>Text Content
Intended for healthcare professionals Our CompanySubscribeMy AccountLogin Open main menu covid-19 Research Education News & Views Campaigns Jobs ArchiveFor authorsHosted Search covid-19 Research Education News & Views Campaigns Jobs ArchiveFor authorsHosted Search TRENDS IN CARDIOVASCULAR DISEASE INCIDENCE AMONG 22 MILLION PEOPLE IN THE UK OVER 20 YEARS TRENDS IN CARDIOVASCULAR DISEASE INCIDENCE AMONG 22 MILLION PEOPLE IN THE UK OVER 20 YEARS Rates of coronary heart disease in the UK have declined by about 30% over the past two decades, but this has been offset by rising rates of other conditions affecting the heart or blood vessels, finds this study ANALGESIA FOR NON-SPECIFIC LOW BACK PAIN This article reviews what is known about common analgesics for treating non-specific low back pain, focusing on adults aged 18-60 years practice | Jun 27 ANALGESIA FOR NON-SPECIFIC LOW BACK PAIN This article reviews what is known about common analgesics for treating non-specific low back pain, focusing on adults aged 18-60 years practice | Jun 27 OBESITY: INTEGRATED CARE BOARDS CLOSE LISTS FOR WEIGHT MANAGEMENT SERVICES AS DEMAND ROCKETS One obesity service reached its three year quota of patients in less than 17 weeks, The BMJ finds news | Jun 26 OBESITY: INTEGRATED CARE BOARDS CLOSE LISTS FOR WEIGHT MANAGEMENT SERVICES AS DEMAND ROCKETS One obesity service reached its three year quota of patients in less than 17 weeks, The BMJ finds news | Jun 26 HOW CAN WE GET MALARIA CONTROL BACK ON TRACK? Promising novel solutions such as vaccines need to be integrated with, rather than replace, existing control measures, says Amal A El-Moamly editorial | Jun 26 HOW CAN WE GET MALARIA CONTROL BACK ON TRACK? Promising novel solutions such as vaccines need to be integrated with, rather than replace, existing control measures, says Amal A El-Moamly editorial | Jun 26 THE NEXT GOVERNMENT SHOULD SUPPORT STAFF TO IMPROVE CARE AND INCREASE INVESTMENT opinion | Jun 27 PREGNANT WOMEN AND OLDER ADULTS IN ENGLAND AND SCOTLAND TO BE OFFERED RSV VACCINATION news | Jun 27 WHAT NEXT FOR UK DEVELOPMENT ASSISTANCE UNDER THE NEXT GOVERNMENT? opinion | Jun 27 DOCTOR POLITICIANS: STICK TO THE EVIDENCE editor's choice | Jun 27 ACTION IS URGENTLY NEEDED ON THE SOCIAL DETERMINANTS OF HEALTH IN THE UK opinion | Jun 27 HISTORY SHOWS THAT DOCTORS’ PROFESSIONAL IDENTITY SHAPES HEALTHCARE DISCOURSE—AND WE MUST NOT IGNORE IT opinion | Jun 26 UNPICKING THE GENERAL ELECTION MANIFESTOS ON HEALTH AND CARE feature | Jun 26 LATEST ARTICLES -------------------------------------------------------------------------------- NEWS E COLI: CONTAMINATED LETTUCE THOUGHT TO BE BEHIND OUTBREAK, AS DEATH IS REPORTED NICE RECOMMENDS NEW GENE THERAPY FOR ADULTS WITH HAEMOPHILIA B TOPIRAMATE: SCREEN PATIENTS FOR PREGNANCY RISK, SAYS DRUG AGENCY BRISTOL GP IS CLEARED OF CRIMINAL DAMAGE AFTER CLIMATE PROTEST ACTION AT TWICKENHAM DOCTORS VOTE FOR BMA TO OPPOSE FOUR YEAR MEDICAL DEGREES AND APPRENTICESHIPS EXTREME HEAT KILLS 1300 HAJJ PILGRIMS THIRD OF ADULTS ARE NOT GETTING ENOUGH PHYSICAL ACTIVITY, SAYS WHO JOHNSON AND JOHNSON PAYS $700M TO 42 US STATES TO SETTLE BABY POWDER ASBESTOS CLAIMS MAIL ON SUNDAY ARTICLES THAT ACCUSED THREE COMMENTATORS OF BEING “STATIN DENIERS” WERE MISINFORMED, JUDGE RULES -------------------------------------------------------------------------------- RESEARCH COLCHICINE IN PATIENTS WITH ACUTE ISCHAEMIC STROKE OR TRANSIENT ISCHAEMIC ATTACK NAB-PACLITAXEL, CISPLATIN, AND CAPECITABINE VERSUS CISPLATIN AND GEMCITABINE AS FIRST LINE CHEMOTHERAPY IN PATIENTS WITH NASOPHARYNGEAL CARCINOMA LATERAL EPISIOTOMY OR IN VACUUM ASSISTED DELIVERY IN NULLIPAROUS WOMEN EXPLORING DIFFERENT OBJECTIVES IN NON-INFERIORITY TRIALS GLOBAL BURDEN OF TYPE 1 DIABETES IN ADULTS AGED 65 YEARS AND OLDER ROBVALU: A TOOL FOR ASSESSING RISK OF BIAS IN STUDIES ABOUT PEOPLE’S VALUES, UTILITIES, OR IMPORTANCE OF HEALTH OUTCOMES ANTIPLATELET THERAPY AFTER CORONARY ARTERY BYPASS SURGERY MAILED FEEDBACK TO PRIMARY CARE PHYSICIANS ON ANTIBIOTIC PRESCRIBING -------------------------------------------------------------------------------- COMMENT REFRAMING THE “HEARTSINK” FEELING CAN HELP DOCTORS FIND A RESOLUTION PREDICTING SUDDEN DEATH … AND OTHER RESEARCH DAVID OLIVER: WILL A LABOUR GOVERNMENT RESCUE ADULT SOCIAL CARE? HELEN SALISBURY: PHYSICIAN ASSOCIATES IN GENERAL PRACTICE—TIME TO PAUSE AND REFLECT SCARLETT MCNALLY: ALTERNATIVE MANIFESTOS CAN HELP US PLAN OUR FUTURE RAMMYA MATHEW: WE NEED BRAVER POLITICS FOR BETTER HEALTH THE DECISION TO RANDOMISE SPECIALISED FOUNDATION PROGRAMME PLACES MUST BE REVISED, IF NOT REVERSED THE NEXT GOVERNMENT MUST SIGNAL TRUST IN GENERAL PRACTICE BY PUTTING MONEY IN THE CORE CONTRACT OBESITY—A VITAL ISSUE THAT’S BEING OVERLOOKED IN THE UK ELECTIONS -------------------------------------------------------------------------------- EDUCATION REDUCING UNNECESSARY INVESTIGATIONS IN PAEDIATRIC SEIZURES IN THE EMERGENCY DEPARTMENT ERYTHRODERMA WITH ISLANDS OF SPARING PATCHY ALOPECIA IN THE CENTRAL POSTERIOR OCCIPITAL REGION ANTIDEPRESSANTS, GLIOMA, . . . AND OTHER STORIES DIAGNOSIS AND MANAGEMENT OF RESISTANT HYPERTENSION RECOGNITION, DIAGNOSIS, AND EARLY MANAGEMENT OF SUSPECTED SEPSIS: SUMMARY OF UPDATED NICE GUIDANCE HELP CREATE AN OPPORTUNITY TO LEARN TOGETHER PIGMENTED SKIN LESIONS MASTERING YOUR YEAR OUT: A GUIDE TO POSTGRADUATE STUDY GAZA ISRAEL IS USING STARVATION AS A WEAPON OF WAR IN GAZA We are witnessing the onset of a man made and entirely preventable famine in Gaza, say Sameer Sah and Khaled Dawas opinion | May 7 THE GLOBAL HEALTH COMMUNITY MUST CALL FOR AN IMMEDIATE CEASEFIRE AND UNRESTRICTED HUMANITARIAN AID IN GAZA Silence from the global health community makes it complicit, argue Fatima Hassan and colleagues opinion | Apr 2 GAZA: ISRAEL BEGINS RAFAH ATTACK DESPITE WHO WARNING OF “BLOODBATH” news | May 9 GAZA: PAEDIATRICIANS CALL ON UK GOVERNMENT TO STOP SELLING ARMS TO ISRAEL news | May 1 GAZA-ISRAEL CONFLICT: WORLD MEDICAL ASSOCIATION BACKS BMA’S CALL FOR SUSTAINABLE CEASEFIRE news | Apr 24 GAZA: HUNDREDS OF BODIES ARE RECOVERED FROM MASS GRAVES AT TWO MAJOR HOSPITALS news | Apr 25 BMJ MEDICINE ASSESSING THE METHODOLOGICAL QUALITY AND RISK OF BIAS OF SYSTEMATIC REVIEWS Carole Lunny and colleagues consider methods such as AMSTAR-2 and ROBIS tools to evaluate the methodological quality and risk of bias of systematic reviews of intervention effects that are included in overviews of reviews May 30 INCIDENCE AND TREATMENT OF GROUP A STREPTOCOCCAL INFECTIONS DURING COVID-19 PANDEMIC AND 2022 OUTBREAK This study by Christine Cunningham and colleagues supports the findings of routine surveillance reports, indicating a reduction in group A streptococcal infections during covid-19 restrictions, followed by a peak in December 2022 May 24 REGULAR USE OF FISH OIL SUPPLEMENTS AND COURSE OF CARDIOVASCULAR DISEASES May 21 DEVELOPMENT OF A NATIONAL CENTILE-BASED MATERNAL EARLY WARNING SCORE May 15 NEONATAL HYPOGLYCAEMIA Apr 9 TO ADJUST OR NOT TO ADJUST: IT IS NOT THE TESTS PERFORMED THAT COUNT, BUT HOW THEY ARE REPORTED AND INTERPRETED Apr 18 UK JOBS -------------------------------------------------------------------------------- Maidstone and Tunbridge Wells NHS Trust: Consultant recruitment information evening Leeds Teaching Hospitals NHS Trust: Consultant in Occupational Medicine The Royal Wolverhampton NHS Trust: Consultant in Neurology Broome Regional Aboriginal Medical Service: General Practitioners NHS Tayside: Consultant in General Internal Medicine HCA Healthcare UK: General Practitioner / Healthscreener - Private Corporate healthcare CURRENT ISSUE All articlesPast issues SGLT-2 INHIBITORS, GLP-1 RECEPTOR AGONISTS, AND DPP-4 INHIBITORS AND RISK OF HYPERKALEMIA AMONG PEOPLE WITH TYPE 2 DIABETES research | Jun 26 WHO ARE THE DOCTORS STANDING AS MPS IN THE UK GENERAL ELECTION? feature | Jun 25 BREAST CANCER SCREENING FROM AGE 40 IN THE US editorial | Jun 24 VITAMIN B12 DEFICIENCY: NICE GUIDELINE SUMMARY practice | Jun 13 MOST READ 1. ULTRA-PROCESSED FOOD EXPOSURE AND ADVERSE HEALTH OUTCOMES: UMBRELLA REVIEW OF EPIDEMIOLOGICAL META-ANALYSES 2. EFFECT OF EXERCISE FOR DEPRESSION: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS 3. ROSUVASTATIN VERSUS ATORVASTATIN TREATMENT IN ADULTS WITH CORONARY ARTERY DISEASE: SECONDARY ANALYSIS OF THE RANDOMISED LODESTAR TRIAL 4. EPIDURAL ANALGESIA DURING LABOUR AND SEVERE MATERNAL MORBIDITY: POPULATION BASED STUDY 5. TRENDS IN CARDIOVASCULAR DISEASE INCIDENCE AMONG 22 MILLION PEOPLE IN THE UK OVER 20 YEARS: POPULATION BASED STUDY 6. SGLT-2 INHIBITORS, GLP-1 RECEPTOR AGONISTS, AND DPP-4 INHIBITORS AND RISK OF HYPERKALEMIA AMONG PEOPLE WITH TYPE 2 DIABETES IN CLINICAL PRACTICE: POPULATION BASED COHORT STUDY COMMUNITY -------------------------------------------------------------------------------- LATEST RESPONSES RE: HOW PARIS IS PREPARING FOR THE HEALTH THREATS OF THE OLYMPIC GAMES -------------------------------------------------------------------------------- RE: BREAST CANCER SCREENING FROM AGE 40 IN THE US -------------------------------------------------------------------------------- RE: NOT “ALL IN THE MIND” -------------------------------------------------------------------------------- RE: LISTENING IS HEALING, LISTENING IS LOVE -------------------------------------------------------------------------------- WE SHOULD INCREASE VACCINATION IN PREGNANCY RATES RATHER THAN MATERNAL VACCINATION RATES -------------------------------------------------------------------------------- View more WHAT ARE YOUR THOUGHTS? Should medical degrees be shortened to four years? Yes No VoteView Results Read related article See all polls ALTMETRICS COVID-19: RESEARCHER BLOWS THE WHISTLE ON DATA INTEGRITY ISSUES IN PFIZER’S VACCINE TRIAL Nov 2, 2021 EFFECTIVENESS OF PUBLIC HEALTH MEASURES IN REDUCING THE INCIDENCE OF COVID-19, SARS-COV-2 TRANSMISSION, AND COVID-19 MORTALITY: SYSTEMATIC REVIEW AND META-ANALYSIS Nov 17, 2021 RISK OF THROMBOCYTOPENIA AND THROMBOEMBOLISM AFTER COVID-19 VACCINATION AND SARS-COV-2 POSITIVE TESTING: SELF-CONTROLLED CASE SERIES STUDY Aug 26, 2021 THE ILLUSION OF EVIDENCE BASED MEDICINE Mar 16, 2022 FOLLOW US ON * Twitter * Facebook * YouTube * RSS CONTENT LINKS * Collections * Health in South Asia * Women’s, children’s & adolescents’ health * Zika virus * Research * Education * News and views * BMJ Opinion * Rapid responses * Archive ABOUT US * About us * Editorial staff * BMJ in the USA * BMJ in South Asia * Advisers * Policies * Submit your paper RESOURCES * Authors * Reviewers * BMA members * Readers * Subscribers * Advertisers and sponsors * Media * Recruiters EXPLORE BMJ * Our company * BMJ Careers * BMJ Learning * BMJ Masterclasses * BMJ Journals * BMJ Student * Academic edition of The BMJ * BMJ Best Practice * The BMJ Awards MY ACCOUNT * Email alerts * Activate subscription INFORMATION * Contact us * Complaints Cookie settingsCookie PolicyPrivacy policyWebsite T&CsRevenue SourcesHighWire PressSitemap Copyright © 2024 BMJ Publishing Group Ltd COOKIES AND PRIVACY We and our 81 partners store and/or access information on a device, such as unique IDs in cookies to process personal data. You may accept or manage your choices by clicking below, including your right to object where legitimate interest is used, or at any time in the privacy policy page. These choices will be signaled to our partners and will not affect browsing data.Cookie policy WE AND OUR PARTNERS PROCESS DATA TO PROVIDE: Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised advertising and content, advertising and content measurement, audience research and services development. List of Partners (vendors) I Accept Reject All Manage preferences ABOUT YOUR PRIVACY * YOUR PRIVACY * STRICTLY NECESSARY COOKIES * PERFORMANCE COOKIES * FUNCTIONAL COOKIES * TARGETING COOKIES * GOOGLE & IAB TCF 2 PURPOSES OF PROCESSING * STORE AND/OR ACCESS INFORMATION ON A DEVICE 52 PARTNERS CAN USE THIS PURPOSE * PERSONALISED ADVERTISING AND CONTENT, ADVERTISING AND CONTENT MEASUREMENT, AUDIENCE RESEARCH AND SERVICES DEVELOPMENT 70 PARTNERS CAN USE THIS PURPOSE * USE PRECISE GEOLOCATION DATA 27 PARTNERS CAN USE THIS PURPOSE * ENSURE SECURITY, PREVENT AND DETECT FRAUD, AND FIX ERRORS 44 PARTNERS CAN USE THIS PURPOSE * DELIVER AND PRESENT ADVERTISING AND CONTENT 49 PARTNERS CAN USE THIS PURPOSE * MATCH AND COMBINE DATA FROM OTHER DATA SOURCES 37 PARTNERS CAN USE THIS PURPOSE * LINK DIFFERENT DEVICES 25 PARTNERS CAN USE THIS PURPOSE * IDENTIFY DEVICES BASED ON INFORMATION TRANSMITTED AUTOMATICALLY 44 PARTNERS CAN USE THIS PURPOSE YOUR PRIVACY We process your data to deliver content or advertisements and measure the delivery of such content or advertisements to extract insights about our website. We share this information with our partners on the basis of consent and legitimate interest. You may exercise your right to consent or object to a legitimate interest, based on a specific purpose below or at a partner level in the link under each purpose. These choices will be signaled to our vendors participating in the Transparency and Consent Framework. Privacy and cookie policies List of IAB Vendors STRICTLY NECESSARY COOKIES Always Active These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information. Cookies Details PERFORMANCE COOKIES Performance Cookies These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. Cookies Details FUNCTIONAL COOKIES Functional Cookies These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly. Cookies Details TARGETING COOKIES Targeting Cookies These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising. Cookies Details GOOGLE & IAB TCF 2 PURPOSES OF PROCESSING Google & IAB TCF 2 Purposes of Processing Allowing third-party ad tracking and third-party ad serving through Google and other vendors to occur. Please see more information on Google Ads https://policies.google.com/privacy?hl=en-US Cookies Details STORE AND/OR ACCESS INFORMATION ON A DEVICE 52 PARTNERS CAN USE THIS PURPOSE Store and/or access information on a device Cookies, device or similar online identifiers (e.g. login-based identifiers, randomly assigned identifiers, network based identifiers) together with other information (e.g. browser type and information, language, screen size, supported technologies etc.) can be stored or read on your device to recognise it each time it connects to an app or to a website, for one or several of the purposes presented here. List of IAB Vendors | View Illustrations PERSONALISED ADVERTISING AND CONTENT, ADVERTISING AND CONTENT MEASUREMENT, AUDIENCE RESEARCH AND SERVICES DEVELOPMENT 70 PARTNERS CAN USE THIS PURPOSE Personalised advertising and content, advertising and content measurement, audience research and services development * USE LIMITED DATA TO SELECT ADVERTISING 50 PARTNERS CAN USE THIS PURPOSE Switch Label Advertising presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type or which content you are (or have been) interacting with (for example, to limit the number of times an ad is presented to you). View Illustrations Object to Legitimate Interests Remove Objection * CREATE PROFILES FOR PERSONALISED ADVERTISING 37 PARTNERS CAN USE THIS PURPOSE Switch Label Information about your activity on this service (such as forms you submit, content you look at) can be stored and combined with other information about you (for example, information from your previous activity on this service and other websites or apps) or similar users. This is then used to build or improve a profile about you (that might include possible interests and personal aspects). Your profile can be used (also later) to present advertising that appears more relevant based on your possible interests by this and other entities. View Illustrations * USE PROFILES TO SELECT PERSONALISED ADVERTISING 35 PARTNERS CAN USE THIS PURPOSE Switch Label Advertising presented to you on this service can be based on your advertising profiles, which can reflect your activity on this service or other websites or apps (like the forms you submit, content you look at), possible interests and personal aspects. View Illustrations * CREATE PROFILES TO PERSONALISE CONTENT 16 PARTNERS CAN USE THIS PURPOSE Switch Label Information about your activity on this service (for instance, forms you submit, non-advertising content you look at) can be stored and combined with other information about you (such as your previous activity on this service or other websites or apps) or similar users. This is then used to build or improve a profile about you (which might for example include possible interests and personal aspects). Your profile can be used (also later) to present content that appears more relevant based on your possible interests, such as by adapting the order in which content is shown to you, so that it is even easier for you to find content that matches your interests. View Illustrations * USE PROFILES TO SELECT PERSONALISED CONTENT 13 PARTNERS CAN USE THIS PURPOSE Switch Label Content presented to you on this service can be based on your content personalisation profiles, which can reflect your activity on this or other services (for instance, the forms you submit, content you look at), possible interests and personal aspects, such as by adapting the order in which content is shown to you, so that it is even easier for you to find (non-advertising) content that matches your interests. View Illustrations * MEASURE ADVERTISING PERFORMANCE 64 PARTNERS CAN USE THIS PURPOSE Switch Label Information regarding which advertising is presented to you and how you interact with it can be used to determine how well an advert has worked for you or other users and whether the goals of the advertising were reached. For instance, whether you saw an ad, whether you clicked on it, whether it led you to buy a product or visit a website, etc. This is very helpful to understand the relevance of advertising campaigns. View Illustrations Object to Legitimate Interests Remove Objection * MEASURE CONTENT PERFORMANCE 34 PARTNERS CAN USE THIS PURPOSE Switch Label Information regarding which content is presented to you and how you interact with it can be used to determine whether the (non-advertising) content e.g. reached its intended audience and matched your interests. For instance, whether you read an article, watch a video, listen to a podcast or look at a product description, how long you spent on this service and the web pages you visit etc. This is very helpful to understand the relevance of (non-advertising) content that is shown to you. View Illustrations Object to Legitimate Interests Remove Objection * UNDERSTAND AUDIENCES THROUGH STATISTICS OR COMBINATIONS OF DATA FROM DIFFERENT SOURCES 43 PARTNERS CAN USE THIS PURPOSE Switch Label Reports can be generated based on the combination of data sets (like user profiles, statistics, market research, analytics data) regarding your interactions and those of other users with advertising or (non-advertising) content to identify common characteristics (for instance, to determine which target audiences are more receptive to an ad campaign or to certain contents). View Illustrations Object to Legitimate Interests Remove Objection * DEVELOP AND IMPROVE SERVICES 44 PARTNERS CAN USE THIS PURPOSE Switch Label Information about your activity on this service, such as your interaction with ads or content, can be very helpful to improve products and services and to build new products and services based on user interactions, the type of audience, etc. This specific purpose does not include the development or improvement of user profiles and identifiers. View Illustrations Object to Legitimate Interests Remove Objection List of IAB Vendors USE PRECISE GEOLOCATION DATA 27 PARTNERS CAN USE THIS PURPOSE Use precise geolocation data With your acceptance, your precise location (within a radius of less than 500 metres) may be used in support of the purposes explained in this notice. List of IAB Vendors ENSURE SECURITY, PREVENT AND DETECT FRAUD, AND FIX ERRORS 44 PARTNERS CAN USE THIS PURPOSE Always Active Your data can be used to monitor for and prevent unusual and possibly fraudulent activity (for example, regarding advertising, ad clicks by bots), and ensure systems and processes work properly and securely. It can also be used to correct any problems you, the publisher or the advertiser may encounter in the delivery of content and ads and in your interaction with them. List of IAB Vendors | View Illustrations DELIVER AND PRESENT ADVERTISING AND CONTENT 49 PARTNERS CAN USE THIS PURPOSE Always Active Certain information (like an IP address or device capabilities) is used to ensure the technical compatibility of the content or advertising, and to facilitate the transmission of the content or ad to your device. List of IAB Vendors | View Illustrations MATCH AND COMBINE DATA FROM OTHER DATA SOURCES 37 PARTNERS CAN USE THIS PURPOSE Always Active Information about your activity on this service may be matched and combined with other information relating to you and originating from various sources (for instance your activity on a separate online service, your use of a loyalty card in-store, or your answers to a survey), in support of the purposes explained in this notice. List of IAB Vendors LINK DIFFERENT DEVICES 25 PARTNERS CAN USE THIS PURPOSE Always Active In support of the purposes explained in this notice, your device might be considered as likely linked to other devices that belong to you or your household (for instance because you are logged in to the same service on both your phone and your computer, or because you may use the same Internet connection on both devices). List of IAB Vendors IDENTIFY DEVICES BASED ON INFORMATION TRANSMITTED AUTOMATICALLY 44 PARTNERS CAN USE THIS PURPOSE Always Active Your device might be distinguished from other devices based on information it automatically sends when accessing the Internet (for instance, the IP address of your Internet connection or the type of browser you are using) in support of the purposes exposed in this notice. List of IAB Vendors Back Button COOKIE LIST Filter Button Consent Leg.Interest checkbox label label checkbox label label checkbox label label Clear checkbox label label Apply Cancel Confirm My Choices Reject All Allow All